» Articles » PMID: 383014

In Vitro Model Simulating the Form of Exposure of Bacteria to Antimicrobial Drugs Encountered in Infection

Overview
Specialty Pharmacology
Date 1979 Jul 1
PMID 383014
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A new model, which is designed to investigate the in vitro activity of antibiotics as a function of different concentration-time curves, is described. The antibiotic is allowed to diffuse through a membrane into a bacterial culture until a peak level is reached; the antibiotic is then removed by flow-assisted back diffusion. With this arrangement it is possible to expose bacteria to a changing concentration of drug while maintaining a constant volume of bacterial culture. Preliminary studies were carried out to investigate the response of a strain of Escherichia coli to gentamicin. The results indicate that bacteria surviving exposure to concentrations of gentamicin similar to those obtained during therapy may exhibit an increase in resistance to the antibiotic.

Citing Articles

Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.

Lowdin E, Odenholt I, Bengtsson S, Cars O Antimicrob Agents Chemother. 1996; 40(11):2478-82.

PMID: 8913449 PMC: 163560. DOI: 10.1128/AAC.40.11.2478.


Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.

Mouton J, den Hollander J Antimicrob Agents Chemother. 1994; 38(5):931-6.

PMID: 8067772 PMC: 188129. DOI: 10.1128/AAC.38.5.931.


Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models.

Keil S, Wiedemann B Antimicrob Agents Chemother. 1995; 39(5):1054-8.

PMID: 7625788 PMC: 162682. DOI: 10.1128/AAC.39.5.1054.


Antibacterial kinetics of ampicillin against Escherichia coli under simulated in vivo conditions.

Fuglesang J, Bergan T Infection. 1982; 10(1):31-4.

PMID: 7040252 DOI: 10.1007/BF01640835.


New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.

Murakawa T, Sakamoto H, Hirose T, Nishida M Antimicrob Agents Chemother. 1980; 18(3):377-81.

PMID: 6999984 PMC: 284009. DOI: 10.1128/AAC.18.3.377.


References
1.
Seal D, Strangeways J . Aminoglycoside resistance due to mutation. Lancet. 1977; 1(8016):856-7. DOI: 10.1016/s0140-6736(77)92805-7. View

2.
Nishida M, Murakawa T, Kamimura T, Okada N . Bactericidal activity of cephalosporins in an in vitro model simulating serum levels. Antimicrob Agents Chemother. 1978; 14(1):6-12. PMC: 352397. DOI: 10.1128/AAC.14.1.6. View

3.
Greenwood D, Ogrady F . An in vitro model of the urinary bladder. J Antimicrob Chemother. 1978; 4(2):113-20. DOI: 10.1093/jac/4.2.113. View

4.
Grasso S, Meinardi G, DE CARNERI I, Tamassia V . New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrob Agents Chemother. 1978; 13(4):570-6. PMC: 352290. DOI: 10.1128/AAC.13.4.570. View

5.
Mawer S, Greenwood D . Specific and non-specific resistance to aminoglycosides in Escherichia coli. J Clin Pathol. 1978; 31(1):12-5. PMC: 476711. DOI: 10.1136/jcp.31.1.12. View